Acelyrin Inc (NASDAQ: SLRN) is -17.83% lower on its value in year-to-date trading and has touched a low of $1.85 and a high of $8.89 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SLRN stock was last observed hovering at around $2.60 in the last trading session, with the day’s loss setting it -0.02%.
Currently trading at $2.58, the stock is 25.18% and 2.12% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 6.09 million and changing -0.77% at the moment leaves the stock -41.18% off its SMA200. SLRN registered -66.23% loss for a year compared to 6-month loss of -46.25%..
The stock witnessed a 31.63% gain in the last 1 month and extending the period to 3 months gives it a -45.34%, and is 21.13% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 5.15% over the week and 6.11% over the month.
Acelyrin Inc (SLRN) has around 130 employees, a market worth around $259.82M and $0.00M in sales. Distance from 52-week low is 39.84% and -70.96% from its 52-week high. The company has generated returns on investments over the last 12 months (-49.44%).
The EPS is expected to grow by 53.73% this year.
Acelyrin Inc (SLRN) Top Institutional Holders
The shares outstanding are 99.94M, and float is at 72.60M with Short Float at 8.08%.
The top institutional shareholder in the company is AYURMAYA CAPITAL MANAGEMENT COMPANY, LP with over 9.33 million shares valued at $41.17 million. The investor’s holdings represent 9.4136% of the SLRN Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 4.74 million shares valued at $20.92 million to account for 4.7835 of the shares outstanding. The other top investors are FMR LLC which holds 4.71 million shares representing 4.754% and valued at over $20.79 million, while MILLENNIUM MANAGEMENT LLC holds 4.6813 of the shares totaling 4.64 million with a market value of $20.47 million.
Acelyrin Inc (SLRN) Insider Activity
The most recent transaction is an insider sale by Becker Daniel J. , the company’s Director. SEC filings show that Becker Daniel J. sold 1 shares of the company’s common stock on Jul 17 ’24 at a price of $6.86 per share for a total of $7.0. Following the sale, the insider now owns 2999.0 shares.
Acelyrin Inc disclosed in a document filed with the SEC on Apr 01 ’24 that Lin Shao-Lee (Chief Executive Officer) sold a total of 9,961 shares of the company’s common stock. The trade occurred on Apr 01 ’24 and was made at $6.63 per share for $66024.0. Following the transaction, the insider now directly holds 1.58 million shares of the SLRN stock.
